LncRNA EPB41L4A-AS1 regulates glycolysis and glutaminolysis by mediating nucleolar translocation of HDAC2.

EBioMedicine
Meijian LiaoYaou Zhang

Abstract

LncRNAs have been found to be involved in various aspects of biological processes. In this study, we aimed to uncover the molecular mechanisms of lncRNA EPB41L4A-AS1 in regulating glycolysis and glutaminolysis in cancer cells. The expression of EPB41L4A-AS1 in cancer patients was analyzed in TCGA and GEO datasets. The level of cellular metabolism was determined by extracellular flux analyzer. The relationship between p53 and EPB41L4A-AS1 was explored by qRT-PCR, luciferase assay and ChIP assay. The interactions between EPB41L4A-AS1 and HDAC2 or NPM1 were determined by RNA immunoprecipitation, RNA pull-down assay and RNA-FISH- immunofluorescence. EPB41L4A-AS1 was a p53-regulated gene. Low expression and deletion of lncRNA EPB41L4A-AS1 were found in a variety of human cancers and associated with poor prognosis of cancer patients. Knock down EPB41L4A-AS1 expression triggered Warburg effect, demonstrated as increased aerobic glycolysis and glutaminolysis. EPB41L4A-AS1 interacted and colocalized with HDAC2 and NPM1 in nucleolus. Silencing EPB41L4A-AS1 reduced the interaction between HDAC2 and NPM1, released HDAC2 from nucleolus and increased its distribution in nucleoplasm, enhanced HDAC2 occupation on VHL and VDAC1 promoter regions...Continue Reading

Citations

Jul 12, 2019·Bioscience Reports·Xiaojian LiLiangsheng Luo
Apr 9, 2020·Biochemical Society Transactions·Mason A McCoolSusan J Baserga
Jul 5, 2019·Cells·Sergei A PirogovMikhail S Klenov
Apr 25, 2020·International Journal of Molecular Sciences·Yunuen Ortiz-PedrazaMarcela Lizano
Aug 11, 2020·Journal of Experimental & Clinical Cancer Research : CR·Qing HanZhiwang Song
Oct 24, 2020·Annals of Surgical Oncology·Hongyi JiangYu Wang
Jan 1, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Han YuZuguang Wu
Oct 31, 2020·Frontiers in Oncology·Soudeh Ghafouri-FardMohammad Taheri
Nov 1, 2020·Cells·Christian T StackhouseChristopher D Willey
Jan 29, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Ziqing WangYaou Zhang
Nov 19, 2020·Scientific Reports·Daniel F ComiskeyAlbert de la Chapelle
Apr 30, 2021·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Mufeng DuYuxin Yin
Aug 24, 2021·Frontiers in Physiology·Federica ZinghirinoFrancesca Guarino
Oct 17, 2021·Journal of Hematology & Oncology·Yiyin ZhangHui Lin

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE44001

Methods Mentioned

BETA
Assay
ChIP
immunoprecipitation
flow cytometry
transfection
acetylation
co-immunoprecipitation
histone

Software Mentioned

Progenetix
SPSS
GSEA
Prism Graph Pad
GSEA ( Gene Enrichment Analysis

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.